论文信息 - Final results of a phase II study of everolimus (RAD001) in metastatic transitional cell carcinoma (TCC) of the urothelium. - 字舞流文

Final results of a phase II study of everolimus (RAD001) in metastatic transitional cell carcinoma (TCC) of the urothelium.

I. Ostrovnaya | M. Milowsky | H. Al-Ahmadie | D. Bajorin | I. Garcia-Grossman | A. Regazzi | S. Gerst | A. Flaherty | A. Trout